Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

Clinical trial NCT01851408 · WITHDRAWN

Trial details

NCT number: NCT01851408
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Recurrent Melanoma Stage III Melanoma Stage IV Melanoma

Start date: 2006-04-01
Primary completion: 2012-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.